jrnl5973

Publication Venue For

  • Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women using the cobas TV/MG test. 2020
  • Clinical validation of the aptima bacterial vaginosis and aptima Candida/Trichomonas vaginitis assays: Results from a prospective multicenter clinical study.  58. 2020
  • Performance of the ALethia CMV assay for detection of cytomegalovirus by use of neonatal saliva swabs.  58. 2020
  • Prospective Evaluation of Molecular Assays for Diagnosis of Vaginitis..  58. 2019
  • Development for Clinical Use of a Multiplexed Immunoassay Using Sputum Samples for Streptococcus pneumoniae: A non-culture-based approach for serotype-specific detection.  57. 2019
  • Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniae.  57. 2019
  • Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a national surveillance program.  57. 2019
  • Molecular testing for mycoplasma genitalium in the United States: Results from the AMES prospective multicenter clinical study.  57. 2019
  • The tail wagging the dog (or the challenges faced when the financing of medicine gets ahead of the science of medicine).  56. 2018
  • Performance of chlamydia trachomatis OmcB enzyme-linked immunosorbent assay in serodiagnosis of chlamydia trachomatis infection in women.  56. 2018
  • Control of artifactual variation in reported intersample relatedness during clinical use of a mycobacterium tuberculosis sequencing pipeline.  56. 2018
  • Diagnostic performance of a molecular test versus clinician assessment of vaginitis.  56. 2018
  • Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel..  56. 2018
  • Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: The serial therapeutic and antifungal monitoring protocol (STAMP) trial.  56. 2018
  • Evaluation of the performance of the cobas CT/NG test for use on the cobas 6800/8800 systems for detection of chlamydia trachomatis and neisseria gonorrhoeae in male and female urogenital samples.  57. 2018
  • Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.  56. 2018
  • Thinking beyond the common Candida species: Need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris.  55:3324-3327. 2017
  • WciG O-acetyltransferase functionality differentiates pneumococcal serotypes 35C and 42.  55:2775-2784. 2017
  • Meatal swabs contain less cellular material and are associated with a decrease in gram stain smear quality compared to urethral swabs in men.  55:2249-2254. 2017
  • Discovery of novel pneumococcal serotype 35D, a natural WciG-deficient variant of serotype 35B.  55:1416-1425. 2017
  • Stability studies on dry swabs and wet mailed swabs for detection of chlamydia trachomatis and neisseria gonorrhoeae in aptima assays.  55:971-977. 2017
  • Answer to photo quiz: Plasmodium falciparum infection with hyperparasitemia.  55:660-661. 2017
  • Photo quiz: A man with fever and headache.  55:351. 2017
  • A pyrosequencing-based approach to high-throughput identification of influenza A(H3N2) virus clades harboring antigenic drift variants.  55:145-154. 2017
  • Combined testing for chlamydia, gonorrhea, and trichomonas by use of the BD max CT/GC/TV assay with genitourinary specimen types.  55:155-164. 2017
  • Clinical Significance of Commensal Gram-Positive Rods Routinely Isolated from Patient Samples..  54:2928-2936. 2016
  • Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes.  54:2470-2484. 2016
  • Closing the Brief Case: Recurrent Granulomatous Mastitis Due to Corynebacterium kroppenstedtii..  54:2212. 2016
  • The Brief Case: Recurrent Granulomatous Mastitis Due to Corynebacterium kroppenstedtii..  54:1938-1941. 2016
  • Pneumococcus with the "6E" CPS locus produces serotype 6B capsular polysaccharide.  54:967-971. 2016
  • Clinical and laboratory testing for trichomonas vaginalis infection.  54:7-12. 2016
  • Comparison of molecular characteristics of mycoplasma pneumonia specimens collected from the United States and China.  53:3891-3893. 2015
  • Investigating the epidemiology of repeat chlamydia trachomatis detection after treatment by Using C. trachomatis OmpA genotyping.  53:546-549. 2015
  • Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system.  52:885-889. 2014
  • A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.  52:2804-2812. 2014
  • Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR (Journal of Clinical Microbiology (2009) 47, 3, (721-726)).  52:3137. 2014
  • Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.  52:1060-1063. 2014
  • ESwab as an optional collection device for use with the Affirm VPIII microbial test system.  52:1698-1700. 2014
  • Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis c outbreak investigation.  52:2650-2652. 2014
  • Reply to "tn4401 Carrying blaKPC is inserted within another insertion in pKpQIL and related plasmids".  52:4450. 2014
  • Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation.  52:758-765. 2014
  • Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women.  51:3694-3699. 2013
  • Diagnostic rates differ on the basis of the number of read days with the use of the Inpouch culture system for Trichomonas Vaginalis screening.  51:3875-3876. 2013
  • Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060)).  51:2806. 2013
  • Performance of the cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  51:1666-1672. 2013
  • Comparison of the abbott m2000 realtime CT assay and the cepheid genexpert CT/NG assay to the roche amplicor CT assay for detection of chlamydia trachomatis in ocular samples from Tanzania.  51:1611-1613. 2013
  • Michael A. Pfaller, M.D..  51:390-392. 2013
  • Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.  50:3542-3547. 2012
  • Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test.  50:3466-3471. 2012
  • Genetic characterization of Trichomonas vaginalis isolates by use of multilocus sequence typing.  50:3293-3300. 2012
  • From quellung to multiplex PCR, and back when needed, in pneumococcal serotyping.  50:2727-2731. 2012
  • Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis.  50:2321-2329. 2012
  • Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  50:2244-2249. 2012
  • Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.  50:2040-2046. 2012
  • Comparative performance of human papillomavirus DNA testing using novel sample collection methods.  49:4185-4189. 2011
  • Molecular testing for Trichomonas vaginalis in women: Results from a prospective U.S. clinical trial.  49:4106-4111. 2011
  • Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.  49:3325-3328. 2011
  • Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms.  49:3033-3035. 2011
  • Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.  49:2818-2826. 2011
  • Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006.  49:2404-2410. 2011
  • Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.  49:2210-2215. 2011
  • Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008.  49:1943-1950. 2011
  • Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation.  49:1646-1649. 2011
  • Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.  49:534-538. 2011
  • Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations.  48:4649-4651. 2010
  • Caught in the act: In vivo development of macrolide resistance to Campylobacter jejuni infection.  48:3012-3015. 2010
  • Cross-reactivity of current serogroup 6 factor sera from Statens Serum Institut with the recently described pneumococcal serotype 6D.  48:3044-3045. 2010
  • Detection and characterization of human Ureaplasma species and serovars by real-time PCR.  48:2715-2723. 2010
  • Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: Comparison of five tissue DNA extraction methods using panfungal PCR.  48:2147-2153. 2010
  • Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.  48:1827-1832. 2010
  • Repetitive extragenic palindromic PCR for study of Streptococcus mutans diversity and transmission in human populations.  48:599-602. 2010
  • Airway obstruction is increased in Pneumocystis-colonized human immunodeficiency virus-infected outpatients.  47:3773-3776. 2009
  • Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network.  47:3138-3141. 2009
  • Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network.  47:3271-3275. 2009
  • Influenza A virus subtyping: Paradigm shift in influenza diagnosis.  47:3055-3056. 2009
  • Diversity of group B streptococcus serotypes causing urinary tract infection in adults.  47:2055-2060. 2009
  • Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations.  47:2353-2354. 2009
  • "Dodgy 6As": Differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction.  47:1981-1982. 2009
  • Ureaplasma parvum as a cause of sternal wound infection.  47:1976-1978. 2009
  • Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections..  47:902-907. 2009
  • Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.  47:721-726. 2009
  • PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.  47:554-559. 2009
  • Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium.  46:3134-3135. 2008
  • Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. academic centers from 1995 to 1999.  46:1285-1291. 2008
  • Cytomegalovirus strain diversity in seropositive women.  46:882-886. 2008
  • Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.  45:3270-3276. 2007
  • USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections.  45:3431-3433. 2007
  • Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in north American women by testing SurePath liquid-based pap specimens in APTIMA assays.  45:2434-2438. 2007
  • Nonsporulating clinical isolate identified as Petromyces alliaceus (Anamorph Aspergillus alliaceus) by morphological and sequence-based methods.  45:2701-2703. 2007
  • Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.  45:1936-1940. 2007
  • Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.  45:1648-1651. 2007
  • Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.  45:1225-1233. 2007
  • Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  45:747-751. 2007
  • GeneChip resequencing of the smallpox virus genome can identify novel strains: A biodefense application.  45:358-363. 2007
  • Methods for detection of Trichomonas vaginalis in the male partners of infected women: Implications for control of trichomoniasis.  44:3994-3999. 2006
  • Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India.  44:3055-3064. 2006
  • Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.  44:3368-3370. 2006
  • Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates.  44:2481-2484. 2006
  • Phaeoacremonium parasiticum infections confirmed by β-tubulin sequence analysis of case isolates.  44:2207-2211. 2006
  • Fluoroquinolone resistance in Ureaplasma parvum in the United States.  44:1590-1591. 2006
  • Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: A multicenter prospective study.  44:1257-1261. 2006
  • Analysis of Mutations within the 5' Untranslated Region, Interferon Sensitivity Region, and PePHD Region as a Function of Response to Interferon Therapy in Hepatitis C Virus-Infected Patients in India.  44:709-715. 2006
  • Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens.  44:366-373. 2006
  • Validation of a multiplex pneumococcal serotyping assay with clinical samples.  44:383-388. 2006
  • Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.  43:5295-5297. 2005
  • Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia.  43:4852-4854. 2005
  • Confirming positive results of Nucleic Acid Amplification Tests (NAATs) for Chlamydia trachomatis: A11 NAATs are not created equal.  43:1372-1373. 2005
  • Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.  43:577-584. 2005
  • Long-term molecular analysis of tuberculosis strains in Alabama, a state characterized by a largely indigenous, low-risk population.  43:870-878. 2005
  • Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.  43:127-131. 2005
  • Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.  43:156-162. 2005
  • Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections.  42:4749-4758. 2004
  • Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.  42:3363-3365. 2004
  • Performance of a new, rapid assay for detection of Trichomonas vaginalis.  42:2940-2943. 2004
  • Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea.  41:5787-5791. 2003
  • Epidemiology of Aspergillus terreus at a University Hospital.  41:5525-5529. 2003
  • Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis.  41:3784-3789. 2003
  • Bacillus cereus bacteremia in a preterm neonate.  41:3441-3444. 2003
  • Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.  41:2458-2464. 2003
  • Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.  41:304-309. 2003
  • Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea.  40:3596-3601. 2002
  • Evaluation of the Digene Hybrid Capture II assay with the Rapid Capture System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  40:3558-3564. 2002
  • Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.  40:3757-3763. 2002
  • Improved detection by DNA amplification of Trichomonas vaginalis in males.  40:3681-3683. 2002
  • Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies.  40:3064-3065. 2002
  • Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis Infection.  40:1555-1557. 2002
  • Comparison of Digene Hybrid Capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.  40:641-644. 2002
  • Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures.  39:4328-4331. 2001
  • Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.  39:3877-3882. 2001
  • Relative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men.  39:3927-3937. 2001
  • Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.  39:3709-3711. 2001
  • Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results.  39:3092-3098. 2001
  • Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens.  39:3197-3199. 2001
  • Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.  39:1008-1016. 2001
  • Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.  39:1092-1096. 2001
  • Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobe.  39:570-573. 2001
  • Evaluation of nucleic acid amplification tests as reference tests for chlamydia trachomatis infections in asymptomatic men.  38:4382-4386. 2000
  • Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.  38:4548-4553. 2000
  • The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters).  38:3133-3134. 2000
  • An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.  38:2043-2050. 2000
  • Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.  38:1731-1734. 2000
  • Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis.  38:1105-1112. 2000
  • Microascus cinereus (anamorph Scopulariopsis) brain abscess in a bone marrow transplant recipient.  38:395-397. 2000
  • Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.  38:3585-3588. 2000
  • InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens.  38:3825-3826. 2000
  • Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.  38:3544-3549. 2000
  • Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.  37:3668-3671. 1999
  • Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.  37:3583-3585. 1999
  • Viability of Trichomonas vaginalis in transport medium.  37:3749-3750. 1999
  • Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assay.  37:3072-3073. 1999
  • Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.  37:2369-2370. 1999
  • Detection of antibody to avian influenza a (H5N1) virus in human serum by using a combination of serologic assays.  37:937-943. 1999
  • Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates.  36:3686-3688. 1998
  • Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.  36:3552-3557. 1998
  • Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens.  36:3234-3238. 1998
  • Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.  36:2229-2234. 1998
  • Evaluation of the biostar chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic.  36:2183-2186. 1998
  • Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels.  36:2052-2056. 1998
  • Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs.  35:2133-2135. 1997
  • Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs.  35:2129-2132. 1997
  • Evaluation of the Vidas Chlamydia test to detect and verify Chlamydia trachomatis in urogenital specimens.  35:2102-2106. 1997
  • Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.  35:1618-1619. 1997
  • Diagnosis of cytomegalovirus infection in pediatric Menetrier's disease by in situ hybridization.  34:2588-2589. 1996
  • Prevalence of fluorescent monoclonal antibody-nonreactive Neisseria gonorrhoeae in five North American sexually transmitted disease clinics.  34:1551-1552. 1996
  • Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group..  34:912-917. 1996
  • Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States.  34:912-917. 1996
  • Comparison of four DNA-based methods for strain delineation of Candida lusitaniae.  33:1467-1470. 1995
  • Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans.  33:1890-1895. 1995
  • Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.  33:455-457. 1995
  • Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.  33:3111-3114. 1995
  • Rapid antigen detection assay for identification of Chlamydia trachomatis infection.  33:1920-1921. 1995
  • Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences.  32:2959-2961. 1994
  • Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men.  32:24-27. 1994
  • Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix.  32:2540-2543. 1994
  • Optimization of quantitative culture assay for human immunodeficiency virus from plasma.  32:3064-3067. 1994
  • Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea.  31:351-353. 1993
  • Application of directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens.  30:1072-1075. 1992
  • Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay.  30:1014-1015. 1992
  • Differentiation of Giardia duodenalis from other Giardia spp. by using polymerase chain reaction and gene probes.  30:74-78. 1992
  • Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection.  30:721-723. 1992
  • Use of a urine enzyme immunoassay as a diagnostic tool for chlamydia trachomatis urethritis in men.  29:2446-2449. 1991
  • Identification of two new antigenic subgroups within the genus Mobiluncus.  29:2204-2208. 1991
  • Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women.  28:2473-2476. 1990
  • Campylobacter-like organisms are uncommon pathogens in patients infected with the human immunodeficiency virus.  28:2370-2371. 1990
  • Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.  28:1541-1544. 1990
  • Demonstration of heterogeneity among the antigenic proteins of Mobiluncus species.  28:463-468. 1990
  • Comparison of GC-Lect and modified Thayer-Martin media for isolation of Neisseria gonorrhoeae.  27:808-811. 1989
  • Effect of differences in specimen processing and passage technique on recovery of Chlamydia trachomatis.  27:894-898. 1989
  • Elevated levels of immunoglobulin A to Giardia lamblia during a waterborne outbreak of gastroenteritis.  27:1707-1710. 1989
  • New fluorescence assay for the quantitation of fungi.  27:2003-2007. 1989
  • Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus.  27:2451-2454. 1989
  • Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.  26:1635-1640. 1988
  • Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults.  26:896-900. 1988
  • Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures.  25:2388-2390. 1987
  • Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics.  25:868-872. 1987
  • Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens.  24:1029-1033. 1986
  • Effect of medium and cultivation conditions on comparisons between latex agglutination and culture detection of group A streptococci.  24:644-646. 1986
  • Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.  23:725-730. 1986
  • Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody.  22:241-244. 1985
  • Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans.  22:259-264. 1985
  • Epidemiological studies of Streptococcus pneumoniae in infants: Development of antibody to phosphocholine.  18:1102-1107. 1983
  • Improved diagnostic accuracy using monoclonal antibody to group A streptococcal carbohydrate.  12:506-508. 1980
  • Atypical isolate of Cryptococcus neoformans cultured from sputum of a patient with pulmonary cancer and blastomycosis.  7:316-318. 1978